RhumbLine Advisers
VAXX

RhumbLine Advisers’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

RhumbLine Advisers’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-44,603
Closed -$32K – 4401
2024
Q1 		$32K Buy
44,603
+5,510
+14% +$3.99K ﹤0.01% 3701
2023
Q4 		$33.2K Hold
39,093
– – ﹤0.01% 3701
2023
Q3 		$53.6K Buy
39,093
+2,657
+7% +$5.76K ﹤0.01% 3629
2023
Q2 		$91.8K Buy
+36,436
New +$77.2K ﹤0.01% 3542

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

RhumbLine Advisers's VAXX Position: Q2 2024 in Review

RhumbLine Advisers sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 44,603 shares — an estimated $32K sold.

RhumbLine Advisers first reported a position in VAXX in Q2 2023 and held it in 4 quarters. The position peaked at $91.8K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • RhumbLine Advisers reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 44,603 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $32K.
  • RhumbLine Advisers first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2023 and held it in 4 quarters.
  • RhumbLine Advisers's Vaxxinity, Inc. Class A Common Stock position peaked at $91.8K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.